Medibio Ltd
ASX:MEB
Medibio Ltd
ASX:MEB
Price:
0.02 AUD
Market Closed
Updated:
May 16, 2024
Section:
Relative Value
The Relative Value of one
MEB
stock under the Base Case scenario is
0.001
AUD.
Compared to the current market price of 0.02 AUD,
Medibio Ltd
is
Overvalued by 96%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MEB
Relative Value
Base Case
0.001
AUD
Overvaluation 96%
Valuation Multiples
Multiples Across Competitors
MEB Competitors Multiples
Medibio Ltd Competitors
Medibio Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Medibio Ltd
ASX:MEB
|
122m AUD | 126.6 | -39.1 | -68.1 | -68.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
34B USD | 14.3 | 64.6 | 64.7 | 69.7 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.5B AUD | 85.6 | 179.5 | 123.5 | 123.5 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.7 | 24.9 | 13.4 | 15.2 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD | 7 | -296 | -128.1 | -117.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.4 | 32.1 | 21.3 | 22.6 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.4B SEK | 27.7 | 106.9 | -70.4 | -70.4 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.7 | -324 | 264.4 | 4 233.4 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
3B USD | 3.8 | -454 | 39.3 | -100.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
